Physiology and Pathophysiology of Incidental Findings Detected on FDG-PET Scintigraphy

Yiyan Liu, Nasrin V. Ghesani, Lionel S. Zuckier

Research output: Contribution to journalReview article

55 Citations (Scopus)

Abstract

A routine feature of positron emission tomography/computed tomography (PET/CT) imaging is whole-body acquisition that results in many unexpected findings identified outside of the primary region of abnormality. Furthermore, 18F-fluorodeoxyglucose (FDG) is a marker of glycolysis and does not specifically accumulate in malignancy. Understanding the physiology and pathophysiology of normal FDG distribution and common incidental findings is therefore essential to the physician interpreting whole-body FDG-PET/CT studies. Whereas many incidental findings are benign and of limited clinical significance, others represent uncommon manifestations of the primary malignancy, second malignancies, or various clinically significant pathologic processes. Patients with a single malignancy are at greater risk of developing synchronous or metachronous second malignancies, possibly related to exposure to shared carcinogenic agents or presence of prooncogenic mutations. The decision of how to pursue an intervention on the basis of an incidental finding is generally left to clinical judgment.

Original languageEnglish (US)
Pages (from-to)294-315
Number of pages22
JournalSeminars in nuclear medicine
Volume40
Issue number4
DOIs
StatePublished - Jul 1 2010
Externally publishedYes

Fingerprint

Incidental Findings
Radionuclide Imaging
Second Primary Neoplasms
Whole Body Imaging
Neoplasms
Normal Distribution
Fluorodeoxyglucose F18
Glycolysis
Pathologic Processes
Physicians
Mutation
Positron Emission Tomography Computed Tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Physiology and Pathophysiology of Incidental Findings Detected on FDG-PET Scintigraphy. / Liu, Yiyan; Ghesani, Nasrin V.; Zuckier, Lionel S.

In: Seminars in nuclear medicine, Vol. 40, No. 4, 01.07.2010, p. 294-315.

Research output: Contribution to journalReview article

@article{47c24bf72a6f46ba8aacd59498fcbedf,
title = "Physiology and Pathophysiology of Incidental Findings Detected on FDG-PET Scintigraphy",
abstract = "A routine feature of positron emission tomography/computed tomography (PET/CT) imaging is whole-body acquisition that results in many unexpected findings identified outside of the primary region of abnormality. Furthermore, 18F-fluorodeoxyglucose (FDG) is a marker of glycolysis and does not specifically accumulate in malignancy. Understanding the physiology and pathophysiology of normal FDG distribution and common incidental findings is therefore essential to the physician interpreting whole-body FDG-PET/CT studies. Whereas many incidental findings are benign and of limited clinical significance, others represent uncommon manifestations of the primary malignancy, second malignancies, or various clinically significant pathologic processes. Patients with a single malignancy are at greater risk of developing synchronous or metachronous second malignancies, possibly related to exposure to shared carcinogenic agents or presence of prooncogenic mutations. The decision of how to pursue an intervention on the basis of an incidental finding is generally left to clinical judgment.",
author = "Yiyan Liu and Ghesani, {Nasrin V.} and Zuckier, {Lionel S.}",
year = "2010",
month = "7",
day = "1",
doi = "10.1053/j.semnuclmed.2010.02.002",
language = "English (US)",
volume = "40",
pages = "294--315",
journal = "Seminars in Nuclear Medicine",
issn = "0001-2998",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Physiology and Pathophysiology of Incidental Findings Detected on FDG-PET Scintigraphy

AU - Liu, Yiyan

AU - Ghesani, Nasrin V.

AU - Zuckier, Lionel S.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - A routine feature of positron emission tomography/computed tomography (PET/CT) imaging is whole-body acquisition that results in many unexpected findings identified outside of the primary region of abnormality. Furthermore, 18F-fluorodeoxyglucose (FDG) is a marker of glycolysis and does not specifically accumulate in malignancy. Understanding the physiology and pathophysiology of normal FDG distribution and common incidental findings is therefore essential to the physician interpreting whole-body FDG-PET/CT studies. Whereas many incidental findings are benign and of limited clinical significance, others represent uncommon manifestations of the primary malignancy, second malignancies, or various clinically significant pathologic processes. Patients with a single malignancy are at greater risk of developing synchronous or metachronous second malignancies, possibly related to exposure to shared carcinogenic agents or presence of prooncogenic mutations. The decision of how to pursue an intervention on the basis of an incidental finding is generally left to clinical judgment.

AB - A routine feature of positron emission tomography/computed tomography (PET/CT) imaging is whole-body acquisition that results in many unexpected findings identified outside of the primary region of abnormality. Furthermore, 18F-fluorodeoxyglucose (FDG) is a marker of glycolysis and does not specifically accumulate in malignancy. Understanding the physiology and pathophysiology of normal FDG distribution and common incidental findings is therefore essential to the physician interpreting whole-body FDG-PET/CT studies. Whereas many incidental findings are benign and of limited clinical significance, others represent uncommon manifestations of the primary malignancy, second malignancies, or various clinically significant pathologic processes. Patients with a single malignancy are at greater risk of developing synchronous or metachronous second malignancies, possibly related to exposure to shared carcinogenic agents or presence of prooncogenic mutations. The decision of how to pursue an intervention on the basis of an incidental finding is generally left to clinical judgment.

UR - http://www.scopus.com/inward/record.url?scp=77952680832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952680832&partnerID=8YFLogxK

U2 - 10.1053/j.semnuclmed.2010.02.002

DO - 10.1053/j.semnuclmed.2010.02.002

M3 - Review article

C2 - 20513451

AN - SCOPUS:77952680832

VL - 40

SP - 294

EP - 315

JO - Seminars in Nuclear Medicine

JF - Seminars in Nuclear Medicine

SN - 0001-2998

IS - 4

ER -